DermTech's latest marketcap:
As of 06/04/2025, DermTech's market capitalization has reached $35. According to our data, DermTech is the 49289th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 35 |
| Revenue (ttm) | 15.66 M |
| Net Income (ttm) | -89,628,000 |
| Shares Out | 35.26 M |
| EPS (ttm) | -2.67 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/01/2025 |
DermTech's yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/04/2025 | $35 | 0% |
| 12/31/2024 | $35 | -100% |
| 12/29/2023 | $59.93 M | 12.05% |
| 12/30/2022 | $53.48 M | -88.61% |
| 12/31/2021 | $469.53 M | -26.14% |
| 12/31/2020 | $635.67 M |
Company Profile
About DermTech, Inc.
DermTech, Inc. is a molecular diagnostic company specializing in non-invasive genomics tests for melanoma detection and skin cancer management. Headquartered in San Diego, California, the company serves pathology and oncology practitioners across the United States.
Key Products & Services
- DermTech Melanoma Test (DMT): A cutting-edge, non-invasive solution designed to improve melanoma detection accuracy.
- DermTech Smart Sticker: Enables non-invasive skin sample collection, reducing the need for traditional scalpel biopsies.
- Research Services & Technology Platform: Provides contract-based solutions for pharmaceutical companies, supporting clinical trials and drug development.
- Gene Expression Assays: Develops assays for psoriasis, atopic dermatitis, and skin aging, aiding pharmaceutical partners in dermatology drug development.
Recent Developments
On June 18, 2024, DermTech, Inc. and its affiliate filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Frequently Asked Questions
-
What is DermTech's (OTC-DMTKQ) current market cap?As of 06/04/2025, DermTech (including the parent company, if applicable) has an estimated market capitalization of $35 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does DermTech (OTC-DMTKQ) rank globally by market cap?DermTech global market capitalization ranking is approximately 49289 as of 06/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.